BARBARA DUNCAN

Profile

First Name

: BARBARA

Middle Name

:

Last Name

: DUNCAN

Related Companies
Titles
Company Name
Related People
DIRECTOR
EDGEMONT PHARMACEUTICALS, LLC
CHRISTINE BLUMHARDT, TIMOTHY MCINERNEY, DOUGLAS A. SALTEL, WARREN STERN, MIKE VACHON, ROBERT ZERBE
EXECUTIVE OFFICER
INTERCEPT PHARMACEUTICALS INC
LUCIANO ADORINI, PAOLO FUNDARO, MARK E. PRUZANSKI, DAVID SHAPIRO, JONATHAN T. SILVERSTEIN, LORENZO TALLARIGO, KLAUS VEITINGER, KLAUS VELTINGER, NICOLE WILLIAMS
DIRECTOR
MEDGENICS, INC.
SCOTT APPLEBAUM, SOL J. BARER, EUGENE ANDREW BAUER, EUGENE ANDREW BAUER, MD, PHYLLIS BELLIN, STEPHEN BELLOMO, ISAAC BLECH, GARY ALLAN BRUKARDT, ALASTAIR CLEMOW, ALASTAIR CLEMOW, PHD, MICHAEL F. COLA, CLARENCE L. DELLIO, WILBUR H. GANTZ, WILBUR H. GANTZ III, JOSEPH J. GRANO JR., JOEL STEPHEN KANTER, JOHN H. LEAMAN, STEPHEN DEVON MCMURRAY, STEPHEN DEVON MCMURRAY, MD, GARRY A. NEIL, ANDREW LEONARD PEARLMAN, ANDREW LEONARD PEARLMAN, PHD, BRIAN PIPER, EHUD SHOSHANI, LEONARD STEINBERG, BARUCH STERN
DIRECTOR
AEVI GENOMIC MEDICINE, INC.
SCOTT APPLEBAUM, SOL J. BARER, EUGENE ANDREW BAUER, EUGENE ANDREW BAUER, MD, PHYLLIS BELLIN, STEPHEN BELLOMO, ISAAC BLECH, GARY ALLAN BRUKARDT, ALASTAIR CLEMOW, ALASTAIR CLEMOW, PHD, MICHAEL F. COLA, CLARENCE L. DELLIO, WILBUR H. GANTZ, WILBUR H. GANTZ III, JOSEPH J. GRANO JR., JOEL STEPHEN KANTER, JOHN H. LEAMAN, STEPHEN DEVON MCMURRAY, STEPHEN DEVON MCMURRAY, MD, GARRY A. NEIL, ANDREW LEONARD PEARLMAN, ANDREW LEONARD PEARLMAN, PHD, BRIAN PIPER, EHUD SHOSHANI, LEONARD STEINBERG, BARUCH STERN
DIRECTOR
JOUNCE THERAPEUTICS, INC.
ANNA L. BARRY, HUGH M. COLE, LUIS A. DIAZ, JR., KIM C. DRAPKIN, KIMBERLEE C. DRAPKIN, DUNCAN HIGGONS, ROBERT IANNONE, ROBERT KAMEN, PERRY KARSEN, RICHARD MURRAY, CARY PFEFFER, CARY G. PFEFFER, ROBERT TEPPER, ELIZABETH G. TREHU
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-10-29
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2020-10-16 
2017-10-19
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Equity 
2017-10-17 
2015-10-15
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2015-10-06 
2012-09-04
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-08-09 
2012-08-24
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-08-09 
2010-12-09
D/A
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2010-03-22